Results 301 to 310 of about 5,282,014 (364)
What's New? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala +10 more
wiley +1 more source
Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer. [PDF]
Chan D +8 more
europepmc +1 more source
A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer [PDF]
Baranski, Thomas +8 more
core +1 more source
What's New? Following the Chernobyl disaster, workers were recruited from formerly Soviet‐occupied areas, including Lithuania, to participate in clean‐up efforts. Radiation exposure incurred by workers during these efforts offers a unique opportunity for the study of long‐term health effects.
Rita Steponaviciene +3 more
wiley +1 more source
Vitamin D deficiency as a potential risk factor for thyroid cancer: a clinical perspective. [PDF]
Yang J +5 more
europepmc +1 more source
Abstract Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and immunosuppressive plasma cells—contribute to immune evasion by secreting inhibitory ...
Zhitong Li +5 more
wiley +1 more source
Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors
What's New? Tumor matrix stiffness plays a critical role in cancer progression, metastasis, and therapy resistance. Here, the authors leveraged tumor RNA‐seq data to identify molecular signatures of mechanical properties across various cancer types and build a computational model for predicting tumor matrix stiffness.
Gongyu Tang +6 more
wiley +1 more source
Remarkable Response to Chemo-immunotherapy In Anaplastic Thyroid Cancer. [PDF]
Carosi F +5 more
europepmc +1 more source
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea +5 more
wiley +1 more source

